Resource:

How One Hospital Is Preparing for Federal and State Dose Regulations

Read this case study to learn how Hahnemann University Hospital worked to comply with Joint Commission radiation dose monitoring/recording regulations.


Case study thumbnail imageHow Hahnemann University Hospital is Tackling the Challenge

A Q&A with Hahnemann University Hospital’s former Director of Radiology, Christopher Lamalfa

Hahnemann University Hospital, part of Tenet Health System, located in Center City Philadelphia is a 500-bed tertiary academic center that serves as a Level 1 trauma center for the surrounding community.

Many healthcare organizations are currently evaluating how to comply with Joint Commission changes coming in July of 2015 specific to dose. As an organization that is already compliant, can you describe key drivers to begin the process and where you started?

In response to the 2010 implementation of California legislation SB 1237 which requires recording of dose in a patient’s record and reporting when it exceeds certain thresholds, Hahnemann University Hospital decided to take the necessary steps to prepare and be compliant before a potential national rollout of the law to better manage risk and patient safety. It was during this time we began to evaluate how technology could help us in the process.

What were the requirements in selecting a technology vendor to prepare for dose transparency, and why were they important to your organization?

Key criteria for a technology partner included ease of implementation, ease of system use, and minimal impact to current workflow. These were important because we did not want to conduct a major IT effort to begin the path towards dose transparency. We could not afford to have departmental downtime with a lengthy implementation of the system, nor could we afford to spend time mapping existing protocols to get started, or be required to impact our existing workflow. Welooked for a solution that was simple to get up and running and was user friendly once installed. All of these factors led to the selection of Imalogix™ in 2012.

Download this case study to read more.